Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival
2 Ansichten
administrator
07/10/23
The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).
Zeig mehr
Facebook Kommentare
Keine Kommentare gefunden